Clinical Trials Logo
  1. Home
  2. Low Cardiac Output Syndrome
  3. NCT00549107

Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants — Levomil  

Low Cardiac Output Syndrome Clinical Trial

Official title:
Phase 2 Prospective, Randomized, Double-Blind Pilot Study on Cardiac Output Following Corrective Open Heart Surgery in Children Less Than One Year: Use of Levosimendan Versus Milrinone.

Clinical Trial Summary

Pediatric patients, especially infants undergoing open heart surgery have a predictable fall in cardiac index 6 to 18 hours after surgery, the so-called low cardiac output syndrome (LCOS). Patients, who have LCOS require more monitoring, more medication and a longer stay in intensive care unit. To prevent LCOS the phosphodiesterase inhibitor milrinone is routinely used during the first 24 hours after surgery. Levosimendan, a calcium- sensitizer improves cardiac muscle contractile force, vascular smooth muscle relaxation and coronary blood flow through calcium sensitization of the myocardial contractile filaments and opening of potassium channels without increasing oxygen consumption of the heart muscle cells. As the myocardium of infants is more calcium dependent than in later life, levosimendan should be of special benefit in this age group. The purpose of this study is to investigate whether levosimendan is superior to milrinone in preventing LCOS in infants after corrective open heart surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00549107
Study type Interventional
Source Ludwig Boltzmann Gesellschaft
Contact Evelyn Lechner, MD
Phone +43505546324706
Email elechner@aon.at
Status Unknown status
Phase Phase 2
Start date September 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT04045340 - Intraoperative Global Longitudinal Strain and Global Longitudinal Strain Rate as Predictors of Unfavorable Outcome in On-Pump Mitral Surgery
Completed NCT00619281 - How Much Cardiac Output is Enough? N/A
Completed NCT01576094 - Two Inodilators Postsurgery in Neonates Phase 1/Phase 2
Completed NCT00994825 - Levosimendan in High Risk Patients Undergoing Cardiac Surgery Phase 4
Completed NCT03143348 - Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass
Completed NCT02025621 - Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass Phase 3
Completed NCT00695929 - Levosimendan in Congenital Cardiac Surgery N/A
Completed NCT03661385 - Nitric Oxide During Bypass for Arterial Switch Operation Phase 3
Completed NCT01120106 - Levosimendan Administration in Neonates With Transposition of the Great Arteries Phase 2
Recruiting NCT03823781 - Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants Phase 3
Completed NCT01328912 - Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients Phase 3
Recruiting NCT03558269 - Autologous Umbilical Cord Blood Treatment of Neonate With CHD Phase 1/Phase 2
Recruiting NCT04405856 - Outcome of Patients Treated With IABP
Recruiting NCT04698005 - Exogenous Ketones for Acutely Decompensated HEart Failure Phase 3
Active, not recruiting NCT05514652 - Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting N/A
Recruiting NCT06355882 - Patients With Low Cardiac Output Syndrome Undergoing Local Dental Anesthesia N/A
Completed NCT03207165 - Milrinone Versus Dobutamine in Critically Ill Patients Phase 4